Several in vitro, in vivo studies and clinical trials provide evidence that supports a causative role of IL-1β in the pathogenesis of type 2 diabetes [15], and elevation in circulating levels of IL-1β predicts type 2 diabetes when combined with serum IL-6 levels [16]. Here, IL6 is linked to type 2 diabetes mellitus.